tanshinone ii a has been researched along with disulfiram in 4 studies
Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (disulfiram) | Trials (disulfiram) | Recent Studies (post-2010) (disulfiram) |
---|---|---|---|---|---|
61 | 0 | 41 | 3,776 | 175 | 723 |
Protein | Taxonomy | tanshinone ii a (IC50) | disulfiram (IC50) |
---|---|---|---|
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 10.1 | |
Spike glycoprotein | Betacoronavirus England 1 | 9.35 | |
Replicase polyprotein 1ab | Betacoronavirus England 1 | 9.35 | |
type-1 angiotensin II receptor | Homo sapiens (human) | 6.637 | |
perilipin-5 | Homo sapiens (human) | 1.622 | |
perilipin-1 | Homo sapiens (human) | 6.959 | |
apelin receptor | Homo sapiens (human) | 2.63 | |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 4.2905 | |
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | Mycobacterium tuberculosis H37Rv | 85.03 | |
Transmembrane protease serine 2 | Homo sapiens (human) | 9.35 | |
Bile salt export pump | Homo sapiens (human) | 10 | |
Carbamate kinase | Giardia intestinalis | 0.6 | |
Retinal dehydrogenase 1 | Homo sapiens (human) | 0.13 | |
Aldehyde dehydrogenase, mitochondrial | Homo sapiens (human) | 3.4 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 4 | |
Procathepsin L | Homo sapiens (human) | 9.35 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 4.904 | |
Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | 1.3756 | |
Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 9.35 | |
Replicase polyprotein 1ab | Human coronavirus 229E | 9.35 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 9.35 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.356 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.9171 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.356 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 3.218 | |
D(1A) dopamine receptor | Homo sapiens (human) | 2.158 | |
D(4) dopamine receptor | Homo sapiens (human) | 3.15 | |
C-X-C chemokine receptor type 2 | Homo sapiens (human) | 6.013 | |
Mitogen-activated protein kinase 3 | Homo sapiens (human) | 1.51 | |
Protein-lysine 6-oxidase | Homo sapiens (human) | 0.32 | |
Lysine-specific demethylase 5A | Homo sapiens (human) | 10 | |
Caspase-1 | Homo sapiens (human) | 1.8 | |
Mu-type opioid receptor | Homo sapiens (human) | 3.511 | |
D(3) dopamine receptor | Homo sapiens (human) | 1.084 | |
Kappa-type opioid receptor | Homo sapiens (human) | 6.103 | |
C-C chemokine receptor type 2 | Homo sapiens (human) | 2.468 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.356 | |
C-C chemokine receptor type 4 | Homo sapiens (human) | 8.395 | |
Gasdermin-D | Homo sapiens (human) | 0.4 | |
Lysyl oxidase homolog 3 | Homo sapiens (human) | 0.093 | |
Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 9.35 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 4.637 | |
NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | 3 | |
Lysyl oxidase homolog 4 | Homo sapiens (human) | 0.059 | |
Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | 0.6 | |
Monoglyceride lipase | Homo sapiens (human) | 0.8095 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 9.35 | |
Gasdermin-D | Mus musculus (house mouse) | 0.4 | |
Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | 1.6 | |
Lysyl oxidase homolog 2 | Homo sapiens (human) | 0.15 | |
large T antigen | Betapolyomavirus macacae | 10.73 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
Hu, Y; Jadhav, P; Tan, B; Tan, H; Wang, J | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 review(s) available for tanshinone ii a and disulfiram
Article | Year |
---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Pandemics; Protease Inhibitors; SARS-CoV-2 | 2022 |
2 other study(ies) available for tanshinone ii a and disulfiram
Article | Year |
---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |